Characterization of Liposomal Systems Entrapping Boron-Containing Compounds in Response to pH Gradients
Boron neutron capture therapy (BNCT) is based on the nuclear reaction that occurs when a stable isotope, Boron-10, is irradiated with low-energy thermal neutrons to yield ionizing Helium and Lithium ions that are highly damaging and usually lethal to cells. The successful treatment of cancer by BNCT requires the selective concentration of Boron-10 within malignant tumors. Liposomes have been used as drug delivery vehicles for in vivo application, including several anticancer agents. The ability of two Boron-containing compounds, 1-p-borono-phenylalanine (BPA) HCl and o-carboranylpropylamine chloride (CPA) to accumulate within unilamellar liposomes passively and in response to a transmembrane pH gradient are compared. Characterization of the obtained systems is performed for conventional and polyethylene glycol (PEG)-modified (stealth) liposomes, in terms of lipid and drug contents, vesicle size and stability. The results indicate that BPA can be successfully encapsulated in conventional liposomes by passive loading, while the active loading approach is more suitable for the entrapment of CPA.
KeywordsActive Loading Boron Neutron Capture Therapy Trapping Efficiency Boron Compound Detergent Concentration
Unable to display preview. Download preview PDF.
- Lasic, D. and Martin, F. (Editors) — Stealth Liposomes, CRC Press, Inc., Boca Raton, 1995.Google Scholar
- Madden, T. D.; Harrigan, P. R.; Tai, L. C. L.; Bally, M. B.; Mayer, L. D.; Redelmeier, T. E.; Loughrey, H. C.; Tilcock, C. P. S.; Reinish, L. W. and Cullis, P. R. — The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey — Chemistry and Physics of Lipids, vol. 53, pp. 37–46, 1990.PubMedCrossRefGoogle Scholar
- Matalka, K. Z.; Bailey, M. Q.; Barth, R. F.; Staubus, A. E.; Soloway, A H.; Moeschberger, M. L.; Coderre, J. A. and Rofstad, E. K. — Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent — Cancer Research, vol. 53, pp. 3308–3313, 1993.PubMedGoogle Scholar
- Mayer, L. D.; Madden, T. D.; Bally, M. B. and Cullis, P. R. — pH Gradient-mediated drug entrapment in liposomes, in Liposome Technology, edited by Gregoriadis, G., 2nd edition, vol.II, pp. 27–44, CRC Press Inc., Boca Raton, 1993.Google Scholar
- New, R. R. C. (Editor) — Liposomes: A Practical Approach, Oxford University Press, Oxford, 1990.Google Scholar
- Nilsson, K.; Almgren, M.; Brown, W. and Jansson, M. — Effects of a non-ionic surfactant on small unilamellar lecithin vesicles — Mol. Cryst. Liq. Cryst., vol. 152, pp. 181–203, 1987.Google Scholar
- Shelly, K.; Feakes, D. A.; Hawthorne, M. F.; Schmidt, P. G.; Krisch, T. A and Bauer, W. F. — Model studies directed toward the boron neutron–capture therapy of cancer: boron delivery to murine tumors with liposomes — Proc. Natl. Acad. Sci. USA, vol. 89, pp. 9039–9043, 1992.PubMedCrossRefGoogle Scholar
- Steffen, D. M. — The effect of cholesterol, phosphatidylethanolamine and immobilized horseradish peroxidase on the stability of phosphatidylcholine vesicles when treated with nonionic surfactant — Master Thesis, Department of Chemical Engineering, NCSU, Raleigh, NC, 1993.Google Scholar
- Yanagié, H.; Tomita, T.; Kobayashi, H.; Fujii, Y.; Takahashi, T.; Hasumi, K.; Nariuchi, H. and Sekiguchi, M. — Application of boronated anti–CEA immunoliposome to tumor cell growth inhibition in in vitro boron neutron capture therapy model — The British Journal of Cancer, vol. 63, No. 4, pp. 522–526, 1991.CrossRefGoogle Scholar